+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
New

Drug Eluting Stent Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337072
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug eluting stent market is evolving rapidly, driven by innovations that address clinical effectiveness and operational efficiency in interventional cardiology. Senior executives face growing expectations to select solutions that meet both provider and system-wide performance benchmarks, making strategic product evaluation critical.

Market Snapshot: Drug Eluting Stent Market Growth and Opportunity

The Drug Eluting Stent Market grew from USD 6.35 billion in 2025 to USD 6.75 billion in 2026. It is expected to continue growing at a CAGR of 8.46%, reaching USD 11.22 billion by 2032. This expansion reflects ongoing advances in device technology, rising clinical demand, and shifting expectations across healthcare delivery systems.

Scope & Segmentation

  • Material Innovations: Includes polymer-coated (biodegradable and durable) and polymer-free stents, with materials influencing healing, elution profiles, and procedural outcomes.
  • Pharmacologic Agents: Focus on biolimus, everolimus, paclitaxel, and sirolimus; agents differentiated by mechanisms for inhibiting neointimal proliferation and enabling device labeling.
  • Clinical Applications: Segmented into coronary artery and peripheral vascular disease use cases, each with specific structural and deliverability needs.
  • Care Settings: Comparison between ambulatory surgical centers, which prioritize inventory and throughput, and hospitals equipped with cath labs and intensive care.
  • Distribution Channels: Hospital pharmacy supply chains, online and retail pharmacy models, and direct-to-provider pathways that affect procurement and device accessibility.
  • Regional Analysis: Includes Americas, Europe Middle East & Africa, and Asia-Pacific; each region’s unique regulatory, reimbursement, and manufacturing ecosystem shapes the adoption landscape.
  • Technology Trends: Next-generation scaffold design, antiproliferative drug selection, image-guided deployment, and integrated digital health solutions impacting clinical precision and post-market monitoring.
[ImageId=a1b2c3d4-e5f6-7g8h-9i0j-k1l2m3n4o5p6]

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Materials science and improved drug elution are reducing complications and supporting expansion into more complex patient anatomies.
  • Advances in digital health and imaging are supporting precise stent deployment, while enabling real-world data collection and longitudinal follow-up.
  • Payers and procurement leaders emphasize value-driven considerations, increasingly weighing total cost of care and device lifecycle management against initial acquisition price.
  • Tariff-related supply chain shifts are prompting manufacturers to reevaluate regional manufacturing and distribution partnerships to sustain operational resilience and margin protection.
  • Collaboration across R&D, clinical, and commercial teams is essential for aligning device design and evidence generation with regulatory and market access requirements in each region.
  • Integrated service offerings, including training and post-market monitoring, are now vital differentiators alongside device performance metrics.

Tariff Impact and Supply Chain Adaptations

Recent tariffs enacted in the U.S. have led to sourcing realignments and new supplier partnerships, affecting both landed costs and procurement strategies. Health systems and manufacturers are prioritizing multi-sourcing, nearshoring, and scenario planning to enhance supply continuity and price stability, while maintaining a focus on innovation pipelines and timely clinical launches. Inventory optimization and strategic contracting have become routine responses to these operational pressures.

Primary Keyword: Drug Eluting Stent Market

Methodology & Data Sources

This analysis integrates structured interviews with clinicians, procurement leaders, and industry executives, supported by comprehensive literature and regulatory review. Cross-validation and expert peer review ensure robust, ethics-driven insights for actionable strategy, with careful attention to confidentiality and data integrity.

Why This Report Matters

  • Delivers a strategic framework tailored to decision-makers navigating clinical, operational, and policy complexities in the drug eluting stent space.
  • Enables informed evaluation of technology, procurement, and manufacturing options—essential for portfolio planning and risk mitigation in dynamic markets.
  • Provides actionable segmentation, regional differentiation, and partnership pathways to refine commercialization and innovation strategies.

Conclusion

The drug eluting stent market is defined by clinical innovation, responsive procurement strategies, and operational agility. Organizations that synchronize evidence, supply chain strength, and service-led commercialization will be best placed for sustained success in interventional care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Drug Eluting Stent Market, by Type
8.1. Polymer Coated
8.1.1. Biodegradable Polymer Coated
8.1.2. Durable Polymer Coated
8.2. Polymer Free
9. Drug Eluting Stent Market, by Drug
9.1. Biolimus Eluting
9.2. Everolimus Eluting
9.3. Paclitaxel Eluting
9.4. Sirolimus Eluting
10. Drug Eluting Stent Market, by Application
10.1. Coronary Artery Disease
10.2. Peripheral Vascular Disease
11. Drug Eluting Stent Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
12. Drug Eluting Stent Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.3. Retail Pharmacy
13. Drug Eluting Stent Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Drug Eluting Stent Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Drug Eluting Stent Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Drug Eluting Stent Market
17. China Drug Eluting Stent Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Biosensors International Group, Ltd.
18.7. BIOTRONIK AG
18.8. Boston Scientific Corporation
18.9. Elixir Medical Corp
18.10. Johnson & Johnson
18.11. Lepu Medical Technology (Beijing) Co., Ltd.
18.12. Medtronic plc
18.13. Meril Life Sciences Private Limited
18.14. MicroPort Scientific Corporation
18.15. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIOLIMUS ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIOLIMUS ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIOLIMUS ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS ELUTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS ELUTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. EUROPE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. EUROPE DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 85. EUROPE DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 86. EUROPE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. EUROPE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. AFRICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 99. AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 100. AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. AFRICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. AFRICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 114. ASEAN DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 115. ASEAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. ASEAN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. ASEAN DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. GCC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GCC DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 120. GCC DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 121. GCC DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 122. GCC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. GCC DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. GCC DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. BRICS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. BRICS DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 134. BRICS DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 135. BRICS DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 136. BRICS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. BRICS DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. BRICS DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. G7 DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. G7 DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 141. G7 DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 142. G7 DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 143. G7 DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. G7 DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. G7 DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. NATO DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. NATO DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148. NATO DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 149. NATO DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 150. NATO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. NATO DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. NATO DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. CHINA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 162. CHINA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 164. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 165. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. CHINA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. CHINA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Drug Eluting Stent market report include:
  • Abbott Laboratories
  • Biosensors International Group, Ltd.
  • BIOTRONIK AG
  • Boston Scientific Corporation
  • Elixir Medical Corp
  • Johnson & Johnson
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Private Limited
  • MicroPort Scientific Corporation
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.75 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.22 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Drug Eluting Stent Market Report 2025 - Product Image

Drug Eluting Stent Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Eluting Balloon Market - Global Forecast 2026-2032 - Product Image

Drug Eluting Balloon Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Drug Eluting Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Drug Eluting Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Drug Eluting Stent Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Drug Eluting Stent Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 98 Pages
  • Global
From

About the Drug Eluting Stent Market

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.